FIELD: chemistry.
SUBSTANCE: present invention relates to a compound of formula: 
which is N-{2-tert-butyl-1-[(4,4-diflurocyclohexyl)methyl]-1H-benzimidazol-5-yl}ethanesulfonamide and its pharmaceutically acceptable salt, their diastereomers, enantiomers or their mixture. The invention also relates to use of this compound in making a medicinal agent with modulator activity of CB1 receptors; to a pharmaceutical composition based on this compound; to a method of modulating CB1 receptors, based on use of effective quantities of this compound, as well as to a method of producing the compound described above.
EFFECT: obtaining a new derivative of benzimidazole with useful biological activity.
8 cl, 1 tbl, 28 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS CONTAINING THEM, OBTAINING AND APPLICATION | 2004 |
|
RU2346938C2 |
| COMPOUNDS HAVING INHIBITORY ACTIVITY RELATIVELY TO PDE9A AND THEIR PHARMACEUTICAL USE | 2019 |
|
RU2788147C2 |
| NEW IMIDAZO[4,5-c]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS | 2018 |
|
RU2773516C2 |
| HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND THEIR USING | 2001 |
|
RU2289581C2 |
| DISPIROPYRROLIDINE DERIVATIVES | 2012 |
|
RU2612534C2 |
| COMPOUNDS HAVING INHIBITORY ACTIVITY RELATIVELY TO PDE9A AND THEIR PHARMACEUTICAL USE | 2019 |
|
RU2788148C2 |
| NEW TETRAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF TUBERCULOSIS | 2018 |
|
RU2800930C2 |
| NEW DERIVATIVES OF IMIDAZO [4,5-C] QUINOLINES AND IMIDAZO [4,5-C] [1,5] NAPHTHYRIDINES AS LRRK2 INHIBITORS | 2016 |
|
RU2722149C1 |
| AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS | 2017 |
|
RU2747318C2 |
| AZAINDAZOLE OR DIAZAINDAZOLE DERIVATIVES AS MEDICINE | 2012 |
|
RU2600976C2 |
